Business & Economy · Oct 17, 2026
The FDA approved phentolamine ophthalmic solution 0.75% for presbyopia, expanding the existing RYZUMVI label. The decision opens a large near vision market, triggers a milestone payment to Opus Genetics and hands Viatris exclusive U.S. commercialization rights, reshaping short term revenue prospects for both firms and the competitive ophthalmics landscape.

Press Release · Oct 15, 2026
The Medicines and Healthcare products Regulatory Agency is updating patient information leaflets for antidepressants to add a boxed warning on suicidal thoughts, include the term Post SSRI Sexual Dysfunction for some drugs, and roll out a patient safety card and ancillary leaflet to improve informed decision making.

Press Release · Oct 8, 2026
Three decades and six industry awards on from pioneering the category, the UK fog generator manufacturer completes its connected platform — BSIA CySPAG cyber accreditation, Ajax and Hikvision integration, remote monitoring and battery-powered deployment.

Technology & AI · Oct 7, 2026
French AI company Mistral has unveiled Large 4, a trillion-parameter multimodal model aimed at strengthening Europe’s position in the global artificial intelligence race while giving organisations greater control through an open-weight approach.

World News · Oct 5, 2026
Swiss President Guy Parmelin arrived in New Delhi on October 5 for a three day state visit focused on deepening economic ties, pushing an investment protection agreement and exploring cooperation on critical technologies amid growing engagement between Switzerland and India.

Press Release · Sep 29, 2026

Business & Economy · Sep 28, 2026
The Union Cabinet approved a formal shift to composite caps for foreign investments, collapsing different foreign holding categories into a single sectoral ceiling. Officials and market participants say the move is intended to reduce regulatory friction and speed foreign capital flows into manufacturing, insurance and other strategic sectors.

Business & Economy · Sep 27, 2026
Benchmark indices fell for a third consecutive week on September 27, 2026, pressured by sustained foreign institutional selling, higher global bond yields and elevated crude prices, even as domestic investors stepped in to cushion the fall.